advertisement

WGC-2021

2.1 Conjunctiva (29)

Showing records 1 to 25

Display all abstracts in classification 2.1 Conjunctiva

Search within classification 2.1 Conjunctiva
86140 Tear and aqueous humour cytokine profile in primary open-angle glaucoma
Burgos-Blasco B
Acta Ophthalmologica 2020; 98: e768-e772
86080 Continuous anti-glaucoma drug therapy as a risk factor of dry eye
Erichev VP
Vestnik Oftalmologii 2019; 135: 117-123
86078 The effect of preservative-free treatment of primary open-angle glaucoma on the state of ocular surface in combination therapy (intermediate results)
Dorofeev DA
Vestnik Oftalmologii 2019; 135: 52-59
86221 Tear Meniscus Imaging by Anterior Segment-Optical Coherence Tomography in Medically Controlled Glaucoma
Agnifili L
Journal of Glaucoma 2020; 29: 374-380
86509 XEN Gel Stent Open Conjunctiva Technique: A Practical Approach Paper
Panarelli JF
Advances in Therapy 2020; 37: 2538-2549
86080 Continuous anti-glaucoma drug therapy as a risk factor of dry eye
Petrov SY; Petrov SY
Vestnik Oftalmologii 2019; 135: 117-123
86140 Tear and aqueous humour cytokine profile in primary open-angle glaucoma
Vidal-Villegas B
Acta Ophthalmologica 2020; 98: e768-e772
86078 The effect of preservative-free treatment of primary open-angle glaucoma on the state of ocular surface in combination therapy (intermediate results)
Tur EV
Vestnik Oftalmologii 2019; 135: 52-59
86080 Continuous anti-glaucoma drug therapy as a risk factor of dry eye
Petrov SY
Vestnik Oftalmologii 2019; 135: 117-123
86509 XEN Gel Stent Open Conjunctiva Technique: A Practical Approach Paper
Yan DB
Advances in Therapy 2020; 37: 2538-2549
86221 Tear Meniscus Imaging by Anterior Segment-Optical Coherence Tomography in Medically Controlled Glaucoma
Brescia L
Journal of Glaucoma 2020; 29: 374-380
86080 Continuous anti-glaucoma drug therapy as a risk factor of dry eye
Petrov SY; Volzhanin AV
Vestnik Oftalmologii 2019; 135: 117-123
86509 XEN Gel Stent Open Conjunctiva Technique: A Practical Approach Paper
Francis B
Advances in Therapy 2020; 37: 2538-2549
86080 Continuous anti-glaucoma drug therapy as a risk factor of dry eye
Volzhanin AV
Vestnik Oftalmologii 2019; 135: 117-123
86078 The effect of preservative-free treatment of primary open-angle glaucoma on the state of ocular surface in combination therapy (intermediate results)
Vizgalova LO
Vestnik Oftalmologii 2019; 135: 52-59
86080 Continuous anti-glaucoma drug therapy as a risk factor of dry eye
Volzhanin AV
Vestnik Oftalmologii 2019; 135: 117-123
86221 Tear Meniscus Imaging by Anterior Segment-Optical Coherence Tomography in Medically Controlled Glaucoma
Scatena B
Journal of Glaucoma 2020; 29: 374-380
86140 Tear and aqueous humour cytokine profile in primary open-angle glaucoma
Saenz-Frances F
Acta Ophthalmologica 2020; 98: e768-e772
86080 Continuous anti-glaucoma drug therapy as a risk factor of dry eye
Volzhanin AV
Vestnik Oftalmologii 2019; 135: 117-123
86221 Tear Meniscus Imaging by Anterior Segment-Optical Coherence Tomography in Medically Controlled Glaucoma
Oddone F
Journal of Glaucoma 2020; 29: 374-380
86509 XEN Gel Stent Open Conjunctiva Technique: A Practical Approach Paper
Craven ER
Advances in Therapy 2020; 37: 2538-2549
86140 Tear and aqueous humour cytokine profile in primary open-angle glaucoma
Morales-Fernandez L
Acta Ophthalmologica 2020; 98: e768-e772
86080 Continuous anti-glaucoma drug therapy as a risk factor of dry eye
Ghazaryan SA
Vestnik Oftalmologii 2019; 135: 117-123
86078 The effect of preservative-free treatment of primary open-angle glaucoma on the state of ocular surface in combination therapy (intermediate results)
Tryapitsin ID; Ciganov AZ
Vestnik Oftalmologii 2019; 135: 52-59
86221 Tear Meniscus Imaging by Anterior Segment-Optical Coherence Tomography in Medically Controlled Glaucoma
Figus M
Journal of Glaucoma 2020; 29: 374-380

Issue 21-2

Change Issue


advertisement

WGW-2021